Please login to the form below

Not currently logged in
Email:
Password:

baloxavir marboxil

This page shows the latest baloxavir marboxil news and features for those working in and with pharma, biotech and healthcare.

Encouraging data for Roche flu drug ahead of FDA decision

Encouraging data for Roche flu drug ahead of FDA decision

Baloxavir marboxil is a single-dose, investigational oral medicine, and has just achieved its primary endpoint in the CAPSTONE-2 trial comparing it with placebo and Tamiflu. ... If approved, baloxavir marboxil will be the first single-dose oral antiviral,

Latest news

  • Roche’s Tamiflu successor hits the mark in complicated flu Roche’s Tamiflu successor hits the mark in complicated flu

    Roche’ s Tamiflu successor hits the mark in complicated flu. Baloxavir marboxil met its primary objective and cut flu-related complications. ... With baloxavir marboxil Roche now looks like it could have a successor to keep its franchise going for the

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics